UBS O'Connor’s VYNE Therapeutics VYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-45,557	Closed	-$72K	–	404
2025 Q1	$72K	Sell	45,557 -200,243	-81%	-$316K	﹤0.01%	229
2024 Q4	$823K	Buy	+245,800	New	+$823K	0.02%	240